Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03136055 |
|---|---|
| Brief Title: | Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas |
| First Submitted : | April 18, 2017 |
| First Submitted that Met QC Criteria : | April 26, 2017 |
| First Posted : | May 2, 2017 |
| Last Update Submitted that Met QC Criteria : | October 8, 2020 |
| Last Update Posted : | October 9, 2020 |